Dartmouth's Norris Cotton Cancer Center (NCCC) submits this competitive renewal application for NCI Cancer Center Support Grant funding for Years 31-35. NCCC is a matrix Center at Dartmouth-Hitchcock Medical Center (DHMC), organized as an interdepartmental component of Dartmouth Medical School and DHMC, with overall responsibility for cancer research, cancer care, and educational and service activities in cancer. NCCC is dedicated to developing strategies to prevent and cure cancer through pioneering interdisciplinary research and translate new knowledge into meaningful preventive and therapeutic approaches. The past five years have been distinguished by significant accomplishments: With the support of its parent institutions, NCCC has taken advantage of its outstanding research facilities to support the growth of its cancer research enterprise, while moving aggressively to a more translational focus on both population-based preventive interventions and clinically based therapeutic research. Over the past funding period, NCCC has (1) strengthened Senior Leadership of the Center;(2) recruited outstanding faculty to strategic priorities;(3) enhanced the infrastructure for research;(4) secured enhanced institutional support;and (5) increased philanthropic resources dedicated to the cancer enterprise. NCCC pursues its mission by promoting collaboration among its 126 scientists and 6 Research Programs, and by facilitating their research efforts through support from 12 Shared Resources. NCCC Research Programs are focused in Cancer Epidemiology/ Chemoprevention, Cancer Control, Molecular Therapeutics, Cancer Mechanisms, Immunology/Cancer Immunotherapy, and Cancer Imaging/ Radiobiology. NCCC Shared Resources provide technology and expertise in Bioinformatics, Biostatistics, Clinical Pharmacology, Flow Cytometry/Cell Imaging, Genomics, Immune Monitoring, Molecular Biology, Pathology, Proteomics, Transgenics/Genetic Constructs, and the Office of Clinical Research. NCCC provides developmental funds to support the initial research efforts of new investigators, innovative and collaborative pilot projects, shared resources, and new technology/methodology. Current total funding for NCCC programs of $54.7M includes $26.5M in NCI-sponsored projects. This application requests continuation of our CCSG to provide partial support for these developmental efforts and for the leadership, administrative, planning and evaluation, shared resources, protocol-specific research, protocol review and monitoring, and other components that are crucial to the maintenance of a coordinated and interactive interdisciplinary program in cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA023108-35S3
Application #
8787204
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
1997-08-04
Project End
2014-11-30
Budget Start
2012-12-01
Budget End
2014-11-30
Support Year
35
Fiscal Year
2014
Total Cost
$1,348,456
Indirect Cost
$516,076
Name
Dartmouth College
Department
Pediatrics
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Durand, Marie-Anne; Yen, Renata West; O'Malley, A James et al. (2018) What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata. BMC Public Health 18:241
Soneji, Samir S; Sung, Hai-Yen; Primack, Brian A et al. (2018) Quantifying population-level health benefits and harms of e-cigarette use in the United States. PLoS One 13:e0193328
Tosteson, Anna N A; Yang, Qian; Nelson, Heidi D et al. (2018) Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs. Breast Cancer Res Treat 167:195-203
Molodtsov, Aleksey; Turk, Mary Jo (2018) Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity. Front Immunol 9:2810
Courtney, Andrea L; Rapuano, Kristina M; Sargent, James D et al. (2018) Brain Reward Responses Are Behaviorally Relevant: The Authors Respond. J Stud Alcohol Drugs 79:41-42
Rutter, Carolyn M; Kim, Jane J; Meester, Reinier G S et al. (2018) Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev 27:158-164
Lin, Anping; Yin, Juan; Cheng, Chao et al. (2018) Decreased expression of FOXA2 promotes eutopic endometrial cell proliferation and migration in patients with endometriosis. Reprod Biomed Online 36:181-187
Elder, David E; Piepkorn, Michael W; Barnhill, Raymond L et al. (2018) Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation. J Am Acad Dermatol 79:52-59.e5
Pernas, Sonia; Martin, Miguel; Kaufman, Peter A et al. (2018) Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial. Lancet Oncol 19:812-824
Kumar, Nishant; Tafe, Laura J; Higgins, John H et al. (2018) Identifying Associations between Somatic Mutations and Clinicopathologic Findings in Lung Cancer Pathology Reports. Methods Inf Med 57:63-73

Showing the most recent 10 out of 1911 publications